References
Ning H, Tao H, Weng Z, Zhao X (2016) Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus. Acta Diabetol 53(6):891–898. doi:10.1007/s00592-016-0867-8
Friebe A, Volk HD (2008) Stability of tumor necrosis factor alpha, interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activation. Arch Pathol Lab Med 132(11):1802–1806. doi:10.1043/1543-2165-132.11.1802
Li YY, Xiao R, Li CP, Huangfu J, Mao JF (2015) Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus. Med Sci Monit Int Med J Exp Clin Res 21:426–431. doi:10.12659/MSM.892431
Kralisch S, Stepan H, Kratzsch J, et al (2009) Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol 160(1):33–38. doi:10.1530/EJE-08-0540
Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, et al (2011) Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care 34(9):2061–2066. doi:10.2337/dc11-0715
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights
This article does not contain any studies with human or animal subjects performed by any of the authors.
Informed consent
For this kind of paper formal consent is not applicable.
Additional information
Managed by Massimo Porta.
Rights and permissions
About this article
Cite this article
Dereke, J., Hillman, M. The significance of biomarkers such as FABP4 in gestational diabetes mellitus and the importance of rigorous peer review. Acta Diabetol 54, 885–886 (2017). https://doi.org/10.1007/s00592-017-1026-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-017-1026-6